DADC
SLXP

D.A. Davidson & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

D.A. Davidson & Co’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-200
Closed -$31K – 2244
2014
Q3 		$31K Buy
+200
New +$29K ﹤0.01% 1568
2013
Q4 		– Sell
-2,485
Closed -$165K – 2185
2013
Q3 		$165K Sell
2,485
-9
-0.4% -$620 0.01% 754
2013
Q2 		$164K Buy
+2,494
New +$143K 0.01% 718

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.A. Davidson & Co's SLXP Position: Q4 2014 in Review

D.A. Davidson & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 200 shares — an estimated $31K sold.

D.A. Davidson & Co first reported a position in SLXP in Q2 2013 and held it in 3 quarters. The position peaked at $165K in Q3 2013. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • D.A. Davidson & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • D.A. Davidson & Co sold 200 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $31K.
  • D.A. Davidson & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 3 quarters.
  • D.A. Davidson & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $165K in Q3 2013.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on D.A. Davidson & Co's 13F filing for Q4 2014, filed 12 Feb 2015.